Propylene glycol alginate sodium sulfate suppressed lung metastasis by blocking P-selectin to recruit CD4 regulatory T cells

• Published in: International journal of biological macromolecules 2024-11, Vol.279 (Pt 2), p.134976, Article 134976
• Main Authors: Xu, Huixin, Ma, He, Li, Yannan, Bi, Shijie, Cai, Kaiyu, Wu, Lijuan, Zhang, Lei, Guan, Huashi, Li, Chunxia, Yang, Jinbo, Qiu, Peiju
• Format: Article
• Language: English
• Subjects: Alginates - chemistry; Alginates - pharmacology; Animals; Cell Line, Tumor; Female; Lung metastasis; Lung Neoplasms - drug therapy; Lung Neoplasms - immunology; Lung Neoplasms - pathology; Lung Neoplasms - secondary; Mice; Neoplasm Metastasis; P-selectin; P-Selectin - metabolism; Propylene glycol alginate sodium sulfate; Regulatory T cells; Sulfated polysarcchrides; T-Lymphocytes, Regulatory - drug effects; T-Lymphocytes, Regulatory - immunology
• ISSN: 0141-8130; 1879-0003; 1879-0003
• DOI: 10.1016/j.ijbiomac.2024.134976

P-selectin has been shown to enhance growth and metastasis of mouse tumors by promoting regulatory T cell (Treg) infiltration into the tumors. Theoretically, a P-selectin antagonist could suppress the process. Popylene glycol alginate sodium sulfate (PSS) is a heparin-like marine drug, which was originally approved to treat cardiovascular disease in China. Previously, we reported that PSS was an effective P-selectin antagonist in vitro. However, it is unknown whether PSS can regulate Treg infiltration and its effect on lung metastasis in vivo. Our results showed that PSS at 30 mg/kg significantly suppressed lung metastasis and improved overall survival, with potency comparable to the positive control LMWH. Mechanistic study indicated that PSS blocked tumor cells adhesion and activated platelets by directly binding with activated platelet's P-selectin. Compared to the model group, PSS decreased the percent of Tregs by 63 % in lungs after treating for 21 days while increasing CD8+ T cells (1.59-fold) and Granzyme B+ CD8 T cells (2.08-fold)’ percentage for generating an adaptive response for systemic tumor suppression. The study indicated that the P-selectin antagonist, PSS, suppressed lung metastasis by inhibiting the infiltration of regulatory T cells (Treg) into the tumors.